文献速递心脏核医学

缺血性心力衰竭患者适当ICD治疗的预测:mIBG与灌注显像的价值

Prediction of appropriate ICD therapy in patients with ischemic heart failure.
PubMed 文献 · J Nucl Cardiol · 2020-08-26

本研究在80例缺血性心力衰竭患者中比较了碘-123-mIBG显像与铊-199灌注显像预测适当ICD治疗(aICDth)的能力,并按ICD植入指征(一级与二级预防)分层。平均随访18个月,一级预防组显像结果无法预测aICDth,而二级预防组中接受aICDth者区域灌注与神经支配损伤的 summed 评分显著更大;mIBG summed 评分预测aICDth的最佳 cut-off 为>34%,灵敏度72%、特异度100%、AUC 0.909、P<0.0001。结论认为神经支配与灌注显像的预后价值因ICD植入指征而异。

要点

  • 一级预防组中mIBG与灌注显像未能预测适当ICD治疗。
  • 二级预防组中aICDth者区域灌注与神经支配损伤summed评分显著更大。
  • mIBG summed评分>34%预测aICDth的灵敏度72%、特异度100%、AUC 0.909。

核心结论

  • 缺血性心力衰竭患者中神经支配与灌注显像的预后价值因ICD植入指征(一级与二级预防)不同而异。

研究设计与样本

  • 在80例缺血性心力衰竭患者ICD植入前进行mIBG与铊-199 SPECT显像,其中49例为心脏性猝死一级预防、31例为二级预防。
  • 平均随访18个月,比较显像结果对适当ICD治疗的预测能力。

主要发现

  • 一级预防组中显像结果无法预测适当ICD治疗。
  • 二级预防组中接受适当ICD治疗者区域灌注与神经支配损伤的summed评分显著更大,但心纵隔mIBG比值未显著更高。
  • mIBG summed评分预测aICDth的最佳cut-off为>34%,灵敏度72%、特异度100%、AUC 0.909、P<0.0001。

关键数值与推荐

  • mIBG summed评分>34%用于预测二级预防组适当ICD治疗,灵敏度72%、特异度100%、AUC 0.909、P<0.0001。

临床怎么用

  • 对缺血性心力衰竭拟行ICD二级预防的患者,可考虑用mIBG summed评分辅助预测适当ICD治疗风险。
  • 一级预防患者中不宜依据mIBG或灌注显像结果预测适当ICD治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies show inconsistent results on the role of innervation imaging (with I-123-mIBG) and perfusion imaging in predicting appropriate ICD therapy (aICDth). These studies included patients with both dilated and ischemic cardiomyopathy. This study compared the ability of 123I-mIBG imaging along with perfusion imaging (using thallium-199) to predict aICDth in patients with ischemic heart failure (IHF) in relation to indication for ICD implantation (primary vs. secondary prevention of sudden cardiac death (SCD)). METHODS: mIBG/thallium SPECT imaging were performed before ICD implantation in 80 patients with IHF: 49 candidates for primary and 31 for secondary SCD prevention. RESULTS: During a mean follow-up of 18 months, the imaging results could not predict patients with appropriate ICD therapy among patients with ICD implants for primary SCD prevention. While in the secondary SCD prevention group, those who received a ICDth had significantly larger summed scores of regional perfusion and innervation impairment, but not higher heart-to-mediastinal mIBG ratio. The best results to predict aICDth were using mIBG summed score (cut-off point > 34%, sensitivity 72%, specificity 100%, AUC 0.909, P < 0.0001). CONCLUSION: The prognostic value of innervation and perfusion imaging in patients with IHF differ based on indication for ICD implantation (primary vs. secondary prevention of SCD).

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Sazonova SI, Atabekov TA, Batalov RE, et al. Prediction of appropriate ICD therapy in patients with ischemic heart failure. J Nucl Cardiol. 2020. PMID: 32851586. doi:10.1007/s12350-020-02321-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。